🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Donald A. Barkauskas

University of Southern California

ORCID: 0000-0002-2339-719X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.5Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma

JCO Precision Oncology(2021)10.1200/po.20.00218
Top 16%
1.3DataRank
Top 16%45 citations

Nicholas Light, Vallijah Subasri, Erin L. Young, Talía Wegman-Ostrosky, Donald A. Barkauskas +21 more

Papers

Driven by 23 papers — median percentile 63. Top paper: “Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma”.

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma

JCO Precision Oncology(2021)10.1200/po.20.00218
Top 16%
1.3DataRank
Top 16%45 citations

Nicholas Light, Vallijah Subasri, Erin L. Young, Talía Wegman-Ostrosky, Donald A. Barkauskas +21 more

Tumor mutational burden is not predictive of cytotoxic chemotherapy response

OncoImmunology(2020)10.1080/2162402x.2020.1781997
N/A
0.989DataRank · unranked
17 citations

Paul Riviere, Aaron M. Goodman, Donald A. Barkauskas, Garrett M. Frampton, Razelle Kurzrock +1 more

Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa204
N/A
0.705DataRank · unranked
109 citations

Saumya D. Sisoudiya, Bailey A. Martin‐Giacalone, Michael M. Khayat, Shannon Dugan‐Perez, Deborah A. Marquez-Do +16 more

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0161
N/A
0.700DataRank · unranked
105 citations

Aaron M. Goodman, Ryosuke Okamura, Donald A. Barkauskas, Theresa J. Whitchurch, Suzanna Lee +9 more

Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00062-5
N/A
0.644DataRank · unranked
13 citations

Anne Aupérin, Simon Bomken, Monika Csóka, Bernarda Kazanowska, Aks Chiang +15 more

Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1376
N/A
0.590DataRank · unranked
16 citations

Alex G. Lee, Steven P. Angus, Christopher Davis, Donald A. Barkauskas, David Hall +10 more

ICOS and ICOS ligand: expression patterns and outcomes in oncology patients

Therapeutic Advances in Medical Oncology(2025)10.1177/17588359251330514
N/A
0.343DataRank · unranked
8 citations

Shumei Kato, Daisuke Nishizaki, Donald A. Barkauskas, Sarabjot Pabla, Mary Nesline +4 more

Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research

JCO Clinical Cancer Informatics(2023)10.1200/cci.23.00104
Top 58%
0.273DataRank
Top 58%4 citations

Qinbo Zhou, Lauren Furman-Cline, Xian Cheng, Danni Luo, Hongyin Lai +21 more

Phase 2 trial of cabozantinib in children and young adults with refractory sarcomas, Wilms tumor, and rare tumors: Children's Oncology Group Study (ADVL1622).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10010
N/A
0DataRank · unranked
26 citations

Brigitte C. Widemann, Donald A. Barkauskas, David Hall, Joel M. Reid, Stephan D. Voss +4 more

Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction

American Journal Of Pathology(2022)10.1016/j.ajpath.2022.03.011
N/A
0DataRank · unranked
34 citations

Shidan Wang, Erin R. Rudzinski, Saloni Agarwal, Ruichen Rong, Donald A. Barkauskas +7 more

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1663
N/A
0DataRank · unranked
28 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients

EJNMMI Research(2020)10.1186/s13550-020-00732-z
N/A
0DataRank · unranked
14 citations

Donald A. Barkauskas, Matthew Zabel, Aaron M. Goodman, Garrett M. Frampton, Mina Nikanjam +3 more

Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children’s Oncology Group

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad055
N/A
0DataRank · unranked
4 citations

Melissa A. Richard, Michael E. Scheurer, Javed Khan, Pagna Sok, Priya B. Shetty +17 more

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10008
N/A
0DataRank · unranked
5 citations

Kathleen Ludwig, David Hall, Donald A. Barkauskas, Stephan D. Voss, Steven G. DuBois +12 more

Data from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

(2023)10.1158/1078-0432.c.6532878.v1
N/A
0DataRank · unranked
0 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4170
N/A
0DataRank · unranked
13 citations

He Li, Michael E. Scheurer, Dana L. Casey, Shannon Dugan‐Perez, Deborah A. Marquez-Do +19 more

Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332

Pediatric Blood & Cancer(2024)10.1002/pbc.31062
N/A
0DataRank · unranked
3 citations

Cheryl M. Coffin, R. Lor Randall, Yan Yang, Donald A. Barkauskas, Lynn Million +5 more

Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children’s Oncology Group study ARST0332

Cancer(2024)10.1002/cncr.35305
N/A
0DataRank · unranked
7 citations

Wei Xue, Zhengya Gao, Andrea Hayes Dixon, Lynn Million, Stephanie F. Polites +10 more

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

UNC Libraries(2024)10.17615/m7sp-3e70
N/A
0DataRank · unranked
0 citations

Shannon Dugan‐Perez, Michael E. Scheurer, Sharon E. Plon, Brian D. Crompton, Philip J. Lupo +19 more

A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10560
N/A
0DataRank · unranked
2 citations

Kathleen Ludwig, Donald A. Barkauskas, Steven G. DuBois, Joan Ronan, Erin R. Rudzinski +10 more

The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children’s Oncology Group

Human Genetics and Genomics Advances(2025)10.1016/j.xhgg.2025.100466
N/A
0DataRank · unranked
0 citations

Christina L. Magyar, Bailey A. Martin‐Giacalone, Michael E. Scheurer, Deborah A. Marquez-Do, Mark Zobeck +17 more

BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0861
N/A
0DataRank · unranked
14 citations

Jose Tinajero, Donald A. Barkauskas, Razelle Kurzrock, Mina Nikanjam

Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma

Sarcoma(2021)10.1155/2021/8324348
N/A
0DataRank · unranked
10 citations

Elif Ugur, B Batko, Jonathan Gill, Michael Roth, Richard Görlick +8 more